TECAN LIMITED

Location

Founded

Website

Risk Signals

224 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Fabricated Structural Metal, Miscellaneous Structural Metal Work, Fabricated Metal Products, Not Elsewhere Classified, Manufacturing Industries, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

New Product Release (29) Public Health Crisis Response (18) Research and Development (16) Environmental Assessments (15) Sustainable Product Design (13) Tech Innovation & Advancements (13) Inter-Organizational Collaborations (12) Research Breakthroughs (11) Business Growth Initiatives (8) Financial Reporting (8) Acquisition Announcements (8) Legal Proceedings (7) Cultural Trends and Innovations (6) Executive Leadership Changes (5) Artificial Intelligence Developments (4) Stock Market Events (4) Market Trends (4) Water Management (3) Cybersecurity Breaches (3) Political and Economic Developments (3) Corporate Governance Policies (3) Competitive Market Dynamics (3) Executive Compensation (3) Data Privacy Regulations (2) Air Quality Monitoring (2) Strategic Partnerships (2) Manufacturing Disruptions (2) Talent Development and Training (2) United States Political Events (2) Automation and Workforce Transformation (2)

Recent Articles about TECAN LIMITED

Live alerts from global media, monitored by Business Radar

A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology

2024-09-30 (biomedcentral.com)

A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology

Immunotherapy has shown marked progress in promoting systemic anti-colorectal cancer (CRC) clinical effects. For further effectively sensitizing CRC to immunotherapy, we have engineered a pH-sensitive zeolitic imidazolate framework-8( CS/NPs), capable of efficient cGAS-STING pathway activation and

Read more
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology

2024-09-30 (biomedcentral.com)

A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade - Journal of Nanobiotechnology

Immunotherapy has shown marked progress in promoting systemic anti-colorectal cancer (CRC) clinical effects. For further effectively sensitizing CRC to immunotherapy, we have engineered a pH-sensitive zeolitic imidazolate framework-8( CS/NPs), capable of efficient cGAS-STING pathway activation and

Read more
Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants - Scientific Data

2023-01-31 (nature.com)

Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants - Scientific Data

Metabolic biomarker data quantified by nuclear magnetic resonance( NMR) spectroscopy in approximately 121,000 UK Biobank participants has recently been released as a community resource, comprising absolute concentrations and ratios of 249 circulating metabolites, lipids, and lipoprotein

Read more

Never miss a headline about TECAN LIMITED

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages